Ahlcon Parenterals (India) Key Ratios
BSE: 524448
₹515.00
As on 21-Jan-2015IST
Market cap
₹371 Cr
Revenue (TTM)
₹176 Cr
P/E Ratio
--
P/B Ratio
4.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -0.51 | -4.12 | 1.85 | 4.11 | 5.35 |
| EBIT | -31.55 | -44.81 | -7.03 | 27.22 | -15.23 |
| Net Profit | -27.60 | -24.95 | -0.48 | 16.57 | -10.68 |
| EPS | -27.60 | -- | 57.93 | 16.57 | -10.68 |
| Book Value | -- | -- | -20.58 | -213.39 | -215.07 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-22 | Mar-21 | Mar-20 |
| EBIT-Margin
| -3.38 | -7.36 | 0.70 | -16.84 | 6.01 |
| Net Margin
| -18.33 | -22.69 | -10.98 | -35.17 | -8.86 |
| Return on equity
| 0.00 | -24.29 | 0.00 | 0.00 | 0.00 |
| Return on Capital
| -0.53 | -2.66 | 2.65 | -8.89 | 4.65 |
| Return on Assets
| -9.74 | -11.26 | -7.33 | -16.82 | -5.07 |
| Debt to Equity (x)
| -- | -- | -2.93 | -3.26 | -6.13 |
Profitability
ROCE
2.65
Lower than Peers by 8.95
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
2.65
|
-8.89
|
4.65
|
-6.72
|
-5.00
|
|
Peer Median
|
11.60
|
11.89
|
12.20
|
15.46
|
15.21
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
--
|
--
|
--
|
--
|
-121.43
|
|
Peer Median
|
11.46
|
13.43
|
10.09
|
12.97
|
9.89
|
ROA
-7.33
Lower than Peers by 13.77
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
-7.33
|
-16.82
|
-5.07
|
-14.59
|
-12.50
|
|
Peer Median
|
6.44
|
7.03
|
5.74
|
5.99
|
5.28
|
EBIT Margin
0.70
Lower than Peers by 11.67
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
0.70
|
-16.84
|
6.01
|
-13.37
|
-13.28
|
|
Peer Median
|
12.37
|
16.50
|
13.87
|
14.56
|
14.68
|
Net Margin
-10.98
Lower than Peers by 21.00
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
-10.98
|
-35.17
|
-8.86
|
-30.21
|
-28.25
|
|
Peer Median
|
10.02
|
10.49
|
8.84
|
10.39
|
9.44
|
Cash Profit Margin
3.24
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
3.24
|
-15.36
|
3.46
|
-9.57
|
-2.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
32.77
Higher than Peers by 23.69
Year on year growth in net sales
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
32.77
|
-24.16
|
12.09
|
4.01
|
10.54
|
|
Peer Median
|
9.08
|
13.45
|
3.43
|
11.25
|
8.37
|
EBIT Growth
105.54
Higher than Peers by 108.66
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
105.54
|
-312.52
|
150.36
|
-4.72
|
-805.39
|
|
Peer Median
|
-3.12
|
18.27
|
3.48
|
28.31
|
22.09
|
Net Profit Growth
57.93
Higher than Peers by 58.78
Year on year growth in profit after tax
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
57.93
|
-201.72
|
67.24
|
-9.56
|
-214.11
|
|
Peer Median
|
-0.85
|
27.20
|
-8.07
|
24.50
|
9.35
|
EPS Growth
57.93
Higher than Peers by 64.75
Year on year growth in earnings per share
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
57.93
|
-201.72
|
67.24
|
-9.56
|
-214.11
|
|
Peer Median
|
-6.82
|
16.28
|
-5.54
|
24.50
|
5.26
|
Book Value Growth
-20.58
--
Year on year growth in book value per share
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
-20.58
|
-95.75
|
-46.49
|
-338.69
|
-75.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-2.93
Lower than Peers by 3.08
Total debt / Net worth
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
-2.93
|
-3.26
|
-6.13
|
-8.82
|
20.57
|
|
Peer Median
|
0.15
|
0.15
|
0.26
|
0.29
|
0.29
|
Short term debt to equity ratio
-0.74
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
-0.74
|
-1.77
|
-3.22
|
-6.59
|
6.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.53
Lower than Peers by 1.55
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
0.53
|
0.14
|
0.29
|
0.24
|
0.23
|
|
Peer Median
|
2.08
|
1.89
|
1.74
|
1.79
|
1.68
|
Quick Ratio
0.33
Lower than Peers by 1.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
0.33
|
0.07
|
0.15
|
0.13
|
0.15
|
|
Peer Median
|
1.58
|
1.64
|
1.32
|
1.39
|
1.25
|
Interest Coverage
0.23
Lower than Peers by 15.18
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
0.23
|
-0.80
|
0.43
|
-0.66
|
-0.57
|
|
Peer Median
|
15.41
|
15.38
|
12.04
|
13.34
|
10.92
|
Operating Efficiency
Debtors to sales
13.82
Lower than Peers by 9.14
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
13.82
|
11.27
|
13.83
|
18.26
|
16.88
|
|
Peer Median
|
22.96
|
20.72
|
22.06
|
19.56
|
23.15
|
Asset Turnover
0.65
Lower than Peers by 0.00
Sales / Average Total Assets
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
0.65
|
0.47
|
0.57
|
0.48
|
0.44
|
|
Peer Median
|
0.65
|
0.61
|
0.51
|
0.69
|
0.73
|
Receivable days
40.71
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
40.71
|
53.87
|
54.97
|
62.94
|
69.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
47.02
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
47.02
|
61.93
|
54.90
|
52.15
|
41.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
58.67
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
58.67
|
99.04
|
96.23
|
107.00
|
66.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
29.05
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
29.05
|
16.76
|
13.65
|
8.08
|
44.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
37.74
|
60.11
|
64.03
|
23.97
|
31.85
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.22
|
3.92
|
3.87
|
2.47
|
2.93
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.57
|
0.56
|
0.61
|
0.79
|
0.56
|
EV/EBITDA
10.58
Lower than Peers by 18.22
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
10.58
|
54.93
|
9.18
|
22.08
|
12.77
|
|
Peer Median
|
28.81
|
25.94
|
28.78
|
21.97
|
23.55
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
|---|---|---|---|---|---|
|
Ahlcon Parenterals (India)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
15,272
|
13,501
|
14,139
|
8,549
|
10,579
|